Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study (2014)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.1111/hiv.12141
- Subjects: PEDIATRIA; FARMACOCINÉTICA; ANTIVIRAIS; INFECÇÕES POR HIV
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2014
- Source:
- Título: HIV Medicine
- ISSN: 1464-2662
- Volume/Número/Paginação/Ano: v. 15, n. 9, p. 513-524, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
TUDOR-WILLIAMS, G. et al. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Medicine, v. 15, n. 9, p. 513-524, 2014Tradução . . Disponível em: https://doi.org/10.1111/hiv.12141. Acesso em: 28 fev. 2026. -
APA
Tudor-Williams, G., Cahn, P., Chokephaibulkit, K., Fourie, J., Karatzios, C., Dincq, S., et al. (2014). Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Medicine, 15( 9), 513-524. doi:10.1111/hiv.12141 -
NLM
Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Nakuda TN, Nijs S, Tambuyzer L, Tomaka FL, Mussi-Pinhata MM. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study [Internet]. HIV Medicine. 2014 ; 15( 9): 513-524.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1111/hiv.12141 -
Vancouver
Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Nakuda TN, Nijs S, Tambuyzer L, Tomaka FL, Mussi-Pinhata MM. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study [Internet]. HIV Medicine. 2014 ; 15( 9): 513-524.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1111/hiv.12141 - Quality assurance program for peripheral blood mononuclear cell cryopreservation
- Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean
- Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean
- Clinical profile of HIV-infected adolescents in Latin America: preliminary report of NICHD international site development initiative pediatric study
- Recem-nascido de baixo peso
- NICDH International Site Developmental Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries
- Laboratory-based surveillance of streptococcus pneumoniae invasive disease (IPD) in children: serotype distribution and estimation of vaccines coverage
- Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants
- Congenital and perinatal cytomegalovirus infection
- Altered natural killerr cell function in HIV-exposed uninfected infants
Informações sobre o DOI: 10.1111/hiv.12141 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
